Blazej Michalski’s Post

This morning, at SCCT 2024, we talked on the progression and regression of coronary plaques. What are your thoughts on the use of artificial intelligence-powered software for qualitative and quantitative plaque analysis? Stay tuned! https://lnkd.in/dFuXGgRk #SCCT2024 Society of Cardiovascular Computed Tomography

This American Heart Month, we're highlighting pivotal research driving advancements in cardiac care. Explore the promise of layer-specific strain imaging in identifying acute myocardial injury, as revealed in the latest study by the Journal of Cardiovascular Magnetic Resonance: https://lnkd.in/gz63UPs5. Learn how you can elevate your clinical practice with MyoStrain's cutting-edge capabilities in acute myocardial injury identification here: https://lnkd.in/dQZ4Sb5p

🎙️For Dominik Doppler, VP of Sales and Marketing at SCHILLER AG, answering the question, "Why should you consider SCHILLER as an option for your medical equipment?" is simple: 50 years of experience and our heritage of quality back us up. We’re at #ESC2024 with the best in cardiac diagnostic technology for you. 🫂🫀 European Society of Cardiology

Did you miss our recent #Cardiovascular webinar? In the presentation, Medpace medical experts delve into the realm of cardiovascular devices, assessing their potential to redefine the trajectory of heart failure. Watch the on-demand #webinar now to explore these emerging cardiovascular devices, from the transformative applications of neuromodulation to interventions for heart failure: https://lnkd.in/gfUauQxe

The Cardiac CT, also known as Coronary CT, is a non-invasive diagnostic examination that utilizes ionizing radiation. It is primarily used for the assessment of the coronary arteries (arterial vessels that supply blood to the myocardial tissue) and associated pathologies, including atherosclerosis. The procedure involves cardio-synchronized acquisition, where the machine synchronizes with the patient's heart rate using electrodes placed on the chest, acquiring images at specific phases of the cardiac cycle (prospective) or across all phases of the cardiac cycle (retrospective). It entails the administration of a high-flow iodinated contrast agent. (The examination is performed using a 64-slice GE CT scanner.) #cardioTC

Discover trending interventional articles: EXPLANT THV, Calcified Nodules in PCI, and more! Stay informed with the latest insights from JACC Journals: Cardiovascular Interventions https://lnkd.in/dTVGJKmx

iVAC 2L - Percutaneous Ventricular Assist Device was introduced at the 7th HKCTO Live event. Dr. Chan Yu Ho, the Clinical Cardiology Director at CUHKMC, delivered a fascinating lecture titled "Update of MCS in Current CHIP PCI."  In his lecture, Dr. Chan introduced a novel perspective on the role of mechanical circulatory support in comparison with the current standard of care for high-risk percutaneous coronary interventions. We appreciate your strong belief dr. Chan Yu Ho, that the iVAC 2L, a mechanical circulatory support device, represents one of the best solutions available for patients undergoing high-risk PCI. PulseCath BV, Doris Xu, #HKCTO #MCS

During a discussion at the Cardiovascular Tech Summit, Dr. Friedhelm Beyersdorf, Professor at the Medical Faculty of Albert-Ludwigs-University Freiburg and ResuSciTec GmbH, highlighted exciting advancements in multi-organ repair through Controlled Automated Reperfusion of the Whole Body (CARL). CARL represents a groundbreaking innovation aimed at addressing the limitations of conventional resuscitation methods, particularly following cardiac arrest. Unlike current techniques, such as a-v ECMO, CARL’s extracorporeal perfusion system is designed to restore cardio-circulatory function while minimizing cellular metabolic damage. Its unique features—including pulsatile arterial blood flow, high-pressure generation, rapid cooling, and advanced monitoring—offer a new approach to reversing ischemic and hypoxic injuries, significantly improving resuscitation outcomes. This individualized strategy for multi-organ repair is poised to be a game-changer in resuscitation. CARL not only restores circulatory function but also incorporates a cytoprotective solution designed for comprehensive organ repair. With ongoing research funding and clinical trials, this innovation holds great potential for enhancing survival rates and long-term recovery after cardiac arrest. Keep an eye on CARL as it continues to reshape emergency and critical care medicine! #CTF2024 #InnovationUpdate #CARL

Our latest Science Says episode dives into the PREVENT study, analyzing whether focal preventive PCI on non-flow-limiting, imaging-defined vulnerable plaques can improve clinical outcomes compared to Optimal Medical Therapy (OMT). We explore findings that preventive PCI, combined with OMT, significantly reduces major cardiac events versus OMT alone. 🖱️Discover our cardiovascular portfolio: https://lnkd.in/eRZXcVnj 🖱️Catch all the Science Says episodes: https://lnkd.in/ek2U3gdi 👩💻Watch now to explore these insights and their implications for future treatments. #wearenipro #Cardiology #MedicalResearch #PreventiveCare #PreventivePCI